The juvenile-onset spondyloarthritides: Rationale for clinical evaluation

Best Practice and Research: Clinical Rheumatology

Volumn 16, Issue 4, 2002, Pages 551-572

  Burgos Vargas, Rubén ^a   Pacheco Tena, César ^b   Vázquez Mellado, Janitzia ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Enthesopathy; Juvenile ankylosing spondylitis; Juvenile arthritis; Outcome measures; Psoriatic arthritis; Spondyloarthropathies

Indexed keywords

ANTIBIOTIC AGENT; ANTIRHEUMATIC AGENT; C REACTIVE PROTEIN; CYCLOSPORIN A; DICLOFENAC; ETANERCEPT; GLUCOCORTICOID; HLA B27 ANTIGEN; IBUPROFEN; INDOMETACIN; INFLIXIMAB; KETOPROFEN; METHOTREXATE; METHYLPREDNISOLONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PREDNISOLONE; SALAZOSULFAPYRIDINE; CYTOKINE RECEPTOR ANTAGONIST; DISEASE MODIFYING ANTIRHEUMATIC DRUG;

ANKYLOSING SPONDYLITIS; ARTHRITIS; AVASCULAR NECROSIS; BONE DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG RESPONSE; ENTHESITIS; FRACTURE; GROWTH DISORDER; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LABORATORY TEST; LOW BACK PAIN; MEDICAL ASSESSMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; OSTEOPOROSIS; OUTCOMES RESEARCH; PHYSIOTHERAPY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSORIATIC ARTHRITIS; QUALITY OF LIFE; REMISSION; REVIEW; SPONDYLOARTHROPATHY; TOTAL HIP PROSTHESIS; UVEITIS; BACTERIAL ARTHRITIS; CROHN DISEASE; HISTOPATHOLOGY; PREVALENCE; PSORIASIS; QUESTIONNAIRE; REACTIVE ARTHRITIS; REITER SYNDROME; AGE; CHILD; SPONDYLITIS;

AGE FACTORS; AGE OF ONSET; CHILD; HUMANS; SPONDYLITIS;

EID: 0036726507     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1053/berh.2002.0247     Document Type: Review

References (87)

1. Rosenberg AM, Petty R, Oen KG et al. Rheumatic diseases in Western Canadian Indian children. Journal of Rheumatology 1982; 9: 589-592.
2. Oen K, Postl B, Chalmers IM et al. Rheumatic diseases in an Inuit population. Arthritis & Rheumatism 1986; 29: 65-74.
3. Boyer GS, Lanier AT & Templin DW. Prevalence rates of spondyloarthropathies, rheumatoid arthritis, and other rheumatic disorders in an Alaskan Inupiat Eskimo population. Journal of Rheumatology 1988; 15: 678-683.
4. Boyer GS, Lanier AT & Templin DW. Spondyloarthropathy and rheumatoid arthritis in Alaskan Yupik Eskimos. Journal of Rheumatology 1990; 17: 489-496.
5. Gare BA. Juvenile arthritis - Who gets it, where and when? A review of current data on incidence and prevalence. Clinical and Experimental Rheumatology 1999; 37: 367-374.
6. Arguedas O, Fasth A, Andersson-Gare B et al. Juvenile chronic arthritis in urban San José, Costa Rica: A 2 year prospective study. Journal of Rheumatology 1998; 25: 1844-1850.
7. Rosenberg AM. Analysis of a pediatric rheumatology clinic population. Journal of Rheumatology 1990; 17: 827-830.
8. Denardo BA, Tucker LB, Miller LC et al. Demography of a regional Pediatric Rheumatology patient population. Journal of Rheumatology 1994; 21: 1553-1561.
9. Bowyer S & Roettcher P and the members of the Pediatric Rheumatology Database Research Group. Pediatric Rheumatology Clinic populations in the United States: Results of a 3 year survey. Journal of Rheumatology 1996; 23: 1968-1974.
10. Symmons DPM, Jones M, Osborne J et al. Pediatric Rheumatology in the United Kingdom: Data from the British Paediatric Rheumatology Group National Diagnostic Register. Journal of Rheumatology 1996; 23: 1975-1980.
11. Malleson PN, Fung MY & Rosenberg AM for the Canadian Pediatric Rheumatology Association. The incidence of pediatric rheumatic diseases: Results from the Canadian Pediatric Rheumatology Association Disease Registry. Journal of Rheumatology 1996; 23: 1981-1987.
12. Lau CS, Burgos-Vargas R, Louthrenoo W et al. Features of spondyloarthropathies around the world. Rheumatic Disease Clinics of North America 1998; 24: 753-770.
13. Minden K, Kiessling U, Listing J et al. Prognosis of patients with juvenile chronic arthritis and juvenile spondyloarthropathy. Journal of Rheumatology 2000; 27: 2256-2263.
14. Masi AT & Wilkins WR. Does male: Female ratio in ankylosing spondylitis change with age? Journal of Rheumatology 1996; 23: 947-948.
15. Burgos-Vargas R, Pacheco-Tena C & Vázquez-Mellado J. Juvenile-onset spondyloarthropathies. Rheumatic Disease Clinics of North America 1997; 23: 569-598.
16. Ladd JR, Cassidy JT & Martel W. Juvenile ankylosing spondylitis. Arthritis & Rheumatism 1971; 14: 579-590.
17. Rosenberg AM & Petty RE. A syndrome of seronegative enthesopathy and arthropathy in children. Arthritis & Rheumatism 1982; 25: 1041-1047.
18. Jacobs JC, Johnston AD & Berdon WE. HLA-B27 associated spondyloarthritis and enthesopathy in childhood: Clinical, pathologic and radiographic observations in 58 patients. Journal of Pediatrics 1982; 100: 5821-5828.
19. Petty RE, Southwood TR, Baum J et al. Revision of the proposed classification for juvenile idiopathic arthritis: Durban 1997. Journal of Rheumatology 1998; 25: 1991-1994.
20. Burgos-Vargas R, Rudwaleit M & Sieper J. The place of juvenile-onset spondyloarthropathies in the Durban 1997 International League Against Rheumatism classification criteria of juvenile idiopathic arthritis. Journal of Rheumatology (in press).
21. Dougados M, Van Der Linden S, Juhlin R et al. The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy. Arthritis & Rheumatism 1991; 34: 1218-1227.
22. Prieuer AM, Listrat V, Dougados M et al. Evaluation of the ESSG and the Amor criteria for juvenile spondyloarthropathies (JSA). Study of 310 consecutive children referred to one pediatric rheumatology center (abstract). Arthritis & Rheumatism 1990; 33 (supplement 9): D195.
23. Prieur AM, Listrat V, Dougados M et al. Criteres de classification des spondyloarthropathies chez les enfants. Arch Fr Pediatr 1993; 50: 379-385.
24. Bennett PH & Burch TA. New York symposium on population studies in the rheumatic diseases: New diagnostic criteria. Bulletin of the Rheumatic Diseases 1967; 17: 453-458.
25. Van Der Linden S, Valkenburg HA & Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York Criteria. Arthritis & Rheumatism 1984; 27: 361-368.
26. Kingsley G & Sieper J. Third international workshop on reactive arthritis. An overview. Annals of the Rheumatic Diseases 1996; 55: 564-570.
27. Southwood TR, Petty RE, Malleson PN et al. Psoriatic arthritis in children. Arthritis & Rheumatism 1989: 32: 1014-1021.
28. Jacobs JC. HLA-B27-associated spondyloarthritis and enthesopathy. In Jacobs JC (ed.) Pediatric Rheumatology for the Practitioner, 1st edn. New York: Springer-Verlag, 1982.
29. Petty RE & Cassidy JT. Juvenile ankylosing spondylitis. In Cassidy JT & Petty RE (eds) Textbook of Pediatric Rheumatology, 4th edn, pp 323-344. Philadelphia: WB Saunders & Co, 2001.
30. Ansell BM. Juvenile spondylitis and related disorders. In Moll JMH (ed.) Ankylosing Spondylitis, pp 120-136. Edinburgh: Churchill Livingstone, 1980.
31. Rosenbaum JT. The eye in spondylarthritides. In Calin A & Taurog JD (eds) The Spondylarthritides, pp 159-166. Oxford: Oxford University Press, 1998.
32. Mielants H, Veys EM, Cuvelier C et al. Gut inflammation in children with late onset pauciarticular juvenile chronic arthritis and evolution to adult spondyloarthropathy - A prospective study. Journal of Rheumatology 1993; 20: 1567-1572.
33. Barabino A, Gattorno M, Cabria M et al. 99mTc-white cell scanning to detect gut inflammation in children with inflammatory bowel diseases or spondyloarthropathies. Clinical and Experimental Rheumatology 1998; 16: 327-334.
34. Lionetti P, Pupi A, Veltroni M et al. Evidence of subclinical intestinal inflammation by 99m technetium leukocyte scintigraphy in patients with HLA-B27 positive juvenile-onset active spondyloarthropathy. Journal of Rheumatology 2000; 27: 1538-1541.
35. Huppertz H, Voigt I, Muller-Scholden J et al. Cardiac manifestations in patients with HLA B27-associated juvenile arthritis. Pediatric Cardiology 2000; 21: 141-147.
36. Camiciottoli G, Trapani S, Ermini M et al. Pulmonary function in children affected by juvenile spondyloarthropathy. Journal of Rheumatology 1999; 26: 1382-1386.
37. Hebestreit H, Muller-Scholden J & Huppertz HI. Aerobic fitness and physical activity in patients with HLA-B27 positive spondyloarthropathy that is inactive or in remission. Journal of Rheumatology 1998; 25: 1626-1633.
38. Shore A & Ansell BM. Juvenile psoriatic arthritis-an analysis of 60 cases. Journal of Pediatrics 1982; 100: 529-535.
39. Petty RE. Juvenile psoriatic arthritis, or juvenile arthritis with psoriasis? Clinical and Experimental Rheumatology 1994; 12 (supplement 10): S55-S58.
40. Ansell BM. Juvenile psoriatic arthritis. Baillières Clinical Rheumatology 1994; 8: 317-332.
41. Hamilton ML, Gladman DD, Shore A et al. Juvenile psoriatic arthritis and HLA antigens. Annals of the Rheumatic Diseases 1990; 49: 694-697.
42. Truckenbrodt H & Häfner R. Psoriatic arthritis in childhood. A comparison with subgroups of chronic juvenile arthritis. Z Rheumatol 1990; 49: 88-94.
43. Southwood TR. Psoriatic arthritis. In Cassidy JT & Petty RE (eds) Textbook of Pediatric Rheumatology, 4th edn, pp 345-356. Philadelphia: WB Saunders & Co, 2001.
44. Hussein A, Stein J & Ehrich JH. C-reactive protein in the assessment of disease activity in juvenile rheumatoid arthritis and juvenile spondyloarthritis. Scandinavian Journal of Rheumatology 1987; 16: 101-105.
45. Burgos-Vargas R & Clark P. Axial involvement in the seronegative enthesopathy and arthropathy syndrome and its progression to ankylosing spondylitis. Journal of Rheumatology 1989; 16: 192-197.
46. Cabral DA, Oen KG & Petty RE. SEA syndrome revisited: A longterm followup of children with a syndrome of seronegative enthesopathy and arthropathy. Journal of Rheumatology 1992; 19: 1282-1285.
47. Burgos-Vargas R & Vásquez-Mellado J. The early clinical recognition of juvenile-onset ankylosing spondylitis and its differentiation from juvenile rheumatoid arthritis. Arthritis & Rheumatism 1995; 38: 835-844.
48. Pacheco-Tena C, Cazarín J, Londoño J et al. A permanent reduction of the spinal movement in juvenile and adult-onset ankylosing spondylitis is explained by involvement of zygapophyseal joints more than by intersomatic changes (abstract). Arthritis & Rheumatology 1999; 42 (supplement): S378.
49. Hall MA, Burgos-Vargas R & Ansell BM. Sacroiliitis in juvenile chronic arthritis: A 10-year follow-up. Clinical and Experimental Rheumatology 1987; 5 (supplement): 65-67.
50. Sheerin KA, Giannini EH, Brewer EJ et al. HLA-B27-associated arthropathy in childhood: Long-term clinical and diagnostic outcome. Arthritis & Rheumatism 1988; 31: 1165-1170.
51. Burgos-Vargas R, Vázquez-Mellado J, Cassis N et al. Genuine ankylosing spondylitis in children: A case control study of patients with definite disease according to current adult-onset criteria shortly after onset. Journal of Rheumatology 1996; 23: 2140-2147.
52. Hussein A. Spectrum of post-enteric reactive arthritis in childhood. Monatsschr Kinderheilkd 1987; 153: 93-98.
53. Cuttica RJ, Scheines EJ, Garay SM et al. Juvenile-onset Reiter's syndrome - A retrospective study of 26 patients. Clinical and Experimental Rheumatology 1992; 10: 285-288.
54. Tacceti G, Trappani S, Ermini M et al. Reactive arthritis triggered by Yersinia enterocolitica: A review of 18 pediatric cases. Clinical and Experimental Rheumatology 1994; 12: 681-685.
55. Kanakoudi-Tsakalidou F, Pardalos G, Prastidou.Gertsi P et al. Persistent or severe course of reactive arthritis following Salmonella enteritidis infection. Scandinavian Journal of Rheumatology 1998; 27: 431-436.
56. Flato B, Aasland A, Vinje O & Forre O. Outcome and predictive factors in juvenile rheumatoid arthritis and juvenile spondyloarthropathy. Journal of Rheumatology 1998; 25: 366-375.
57. Calin A & Elswood S. The natural history of juvenile-onset ankylosing spondylitis: 24 year retrospective case control study. British Journal of Rheumatology 1988: 27: 91-93.
58. García-Morteo O, Maldonado-Cocco JA, Suárez-Almazor ME et al. Ankylosing spondylitis of juvenile-onset: Comparison with adult-onset disease. Scandinavian Journal of Rheumatology 1983; 12: 246-248.
59. Jiménez J & Mintz G. The onset, evolution and final stages of juvenile ankylosing spondylitis are different from those of adult-onset ankylosing spondylitis. In Dick CA & Calabro JJ (eds) Ankylosing Spondylitis, 1st edn. Lancaster: MTP Press, 1987.
60. Goycochea-Robles MV, Ortíz-Alvarez O, Garduño-Espinoza J et al. Development and validation of an index to measure disease activity in patients with juvenile-onset spondyloarthropathies (abstract). Arthritis & Rheumatism 2000; 43 (supplement): S138.
61. Van Der Heijde D, Bellamy N, Calin A et al. Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group. Journal of Rheumatology 1997; 24: 2225-2229.
62. Van Der Heijde D, Calin A, Dougados M et al. Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis. Journal of Rheumatology 1999; 26: 951-954.
63. Garrett S, Jenkinson T, Kennedy LG et al. A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). Journal of Rheumatology 1994; 21: 2286-2291.
64. Calin A, Garrett S, Whitelock H et al. A new approach to defining functional ability in ankylosing spondylitis: The development of the Bath Ankylosing Functional Index (BASFI). Journal of Rheumatology 1994; 21: 2281-2285.
65. Dougados M, Gueguen A, Nakache J-P et al. Evaluation of a functional index and an articular index in ankylosing spondylitis. Journal of Rheumatology 1988; 15: 302-307.
66. Spoorenberg A, Van Der Heijde D, DE Klerk E et al. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. Journal of Rheumatology 1999; 26: 980-984.
67. MacKay K, Mack C, Brophy S et al. The Bath ankylosing spondyilitis radiology index (BASRI), a new validated approach to disease assessment. Arthritis & Rheumatism 1998; 41: 2263-2270.
68. MacKay K, Brophy S, Mack C et al. The development and validation of a radiographic grading system for the hip in ankylosing spondylitis; The Bath ankylosing spondylitis radiology hip index. Journal of Rheumatology 2000; 27: 2866-2872.
69. Pacheco-Tena C, Londoño JD, Cazarín-Barrientos J et al. Development of a radiographic index to assess the tarsal involvement in patients with spondyloarthropathies. Annals of the Rheumatic Diseases 2002; 61: 330-334.
70. Brewer EJ, Bass J, Baum J et al. Current proposed revision of JRA criteria. Arthritis & Rheumatism 1977; 20 (supplement): 195-199.
71. Wood PF. Special meeting on: Nomenclature and classification of arthritis in children. In Munthe E (ed.) The Care of the Rheumatic Children pp 47-50. EULAR Monograph series no. 3. Basle: EULAR Publishers, 1978.
72. De Inocencio J & Lovell DJ. Clinical and functional monitoring, outcome measures and prognosis of juvenile chronic arthritis. Ballière's Clinical Paediatrics 1993; 1: 769-801.
73. Guzmán J, Burgos-Vargas R, Duarte-Salazar C et al. Reliability of the articular examination in children with juvenile rheumatoid arthritis: Interobserver agreement and sources of disagreement. Journal of Rheumatology 1995; 22: 2331-2336.
74. Ravelli A, Viola S, Migliavacca D et al. Discordance between proxy-reported and observed assessment of functional ability of children with juvenile idiopathic arthritis. Rheumatology 2001; 40: 914-919.
75. Duffy CM & Lovell DJ. Assessment of health status, function, and outcome. In Cassidy JT & Petty RE (eds) Textbook of Pediatric Rheumatology, 4th edn, pp 178-187. Philadelphia: WB Saunders & Co, 2001.
76. Singh G, Athreya BH, Fries JF et al. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis & Rheumatism 1994; 37: 1761-1769.
77. Ruperto N, Ravelli A, Pistorio A et al. Paediatric Rheumatology International Trials Organisation. Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries. Review of the general methodology. Clinical and Experimental Rheumatology 2001; 19 (supplement 23): S1-S9.
78. Landgraf JM, Abetz & Ware JE Jr. The Child Health Questionnaire: A User Manual. Boston, MA: The Health Institute, New England Medical Center, 1996.
79. Varni JW, Seid M & Rode CA The PedsQL: Measurement model for the Pediatric Quality of Life Inventory. Med Care 1999; 37: 126-139.
80. Anderson JJ, Baron G, Van Der Heijde D et al. Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis & Rheumatism 2001; 44: 1876-1886.
81. Giannini EH, Ruperto N, Ravelli A et al. Preliminary definition of improvement in juvenile arthritis. Arthritis & Rheumatism 1997; 40: 1202-1209.
82. Riley MJ, Ansell BM & Bywaters EGL. Radiological manifestations of ankylosing spondylitis according to age at onset. Annals of the Rheumatic Diseases 1971; 30: 138-148.
83. Marks S, Bennett M & Calin A. The natural history of juvenile ankylosing spondylitis: A case control study of juvenile and adult-onset disease. Journal of Rheumatology 1982; 9: 739-741.
84. Burgos-Vargas R, Naranjo A, Castillo J et al. Ankylosing spondylitis in the Mexican Mestizo: Patterns of disease according to age at onset. Journal of Rheumatology 1989; 16: 186-191.
85. Moran HM, Hall MA, Barr A et al. Spinal mobility in the adolescent. Rheumatology and Rehabilitation 1979; 18: 181-185.
86. Burgos-Vargas R, Lardizabal-Sanabria J & Katona G. Anterior spinal flexion in healthy Mexican children. Journal of Rheumatology 1985; 12: 123-125.
87. Burgos-Vargas R, Castelazo-Duarte G, Orozco JA et al. Chest expansion in healthy adolescents and in patients with juvenile ankylosing spondylitis or the seronegative enthesopathy and arthropathy syndrome. Journal of Rheumatology 1993; 20: 1957-1969.